Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma

Clinical trial NCT06364826 · UNKNOWN

Trial details

NCT number: NCT06364826
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2024-04-22
Primary completion: 2026-04-22
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.